FDA.reportPublic FDA data

mesalamine 1200 MG Delayed Release Oral Tablet [Lialda]

RxCUI
686433
RxNorm name
mesalamine 1200 MG Delayed Release Oral Tablet [Lialda]
Display name
mesalamine 1200 MG Delayed Release Oral Tablet [Lialda]
Full name
mesalamine 1200 MG Delayed Release Oral Tablet [Lialda]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LialdaMESALAMINETakeda Pharmaceuticals America, Inc.3098a080-be86-4265-9818-7fc4beab77b72026-03-24Warnings, Adverse reactionsExact identifier
rxcui: 686433

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3098a080-be86-4265-9818-7fc4beab77b7Lialda 1. 2 GM Delayed Release Oral Tablet, Once-Daily [PSN] · mesalamine 1200 MG Delayed Release Oral Tablet [Lialda] [SBD] · Lialda 1.2 GM Delayed Release Oral Tablet [SY] · Lialda 1200 MG Delayed Release Oral Tablet [SY]449These highlights do not include all the information needed to use LIALDA safely and effectively. See full prescribing information for LIALDA. LIALDA ® (mesalamine) delayed-release tablets, for oral use Initial U.S. Approval: 198720260324